Elevance Health Is Maintained at Buy by TD Cowen
Elevance Health Is Maintained at Buy by TD
Express News | TD Cowen Maintains Buy on Elevance Health, Lowers Price Target to $589
Baird Adjusts Price Target on Elevance Health to $625 From $649
Elevance Health (ELV) has an average rating of outperform and price targets ranging from $550 to $665, according to analysts by Capital IQ.Price: 503.00, Change: -1.72, Percent Change: -0.34
Elevance Health Second Quarter 2024 Earnings: EPS Beats Expectations
Express News | Elevance Health Inc : TD Cowen Cuts Target Price to $589 From $624
BofA Downgrades Elevance Health On Medicaid Pressure And Lowered Peer Valuations
Wednesday, Elevance Health Inc. (NYSE:ELV) reported second-quarter revenues of $43.2 billion, down 0.4% year-over-year, marginally above the consensus of $43.05 billion. The decrease was driven by
Elevance Health's Medicaid Margin Outlook Has BofA Taking Sideline -- Market Talk
1359 ET - Managed care provider Elevance Health said Medicaid membership attrition was only partially offset by premium rate increases to reflect medical cost trends, when it reported operating
A Closer Look at Elevance Health's Options Market Dynamics
Financial giants have made a conspicuous bearish move on Elevance Health. Our analysis of options history for Elevance Health (NYSE:ELV) revealed 8 unusual trades.Delving into the details, we found 12
Elevance Health, Other Health Benefits Firms Face 'Cloudy' Future, BofA Says
Elevance Health (ELV) reported better-than-expected Q2 results and reiterated its 2024 financial forecast, overcoming a double-digit decline in memberships for Medicaid plans, although that did
Express News | Elevance Health Shares Are Trading Lower After B of A Securities Downgraded the Stock From Buy to Neutral and Cut Its Price Target From $646 to $530
Elevance Extends Losses as BofA Cuts on Medicaid Headwinds
Elevance Health Price Target Raised to $585.00/Share From $575.00 by RBC Capital
Elevance Health Price Target Raised to $585.00/Share From $575.00 by RBC
Elevance Health Is Maintained at Outperform by RBC Capital
Elevance Health Is Maintained at Outperform by RBC
Express News | Elevance Health Inc : BofA Global Research Cuts to Neutral From Buy; Cuts Price Objective to $530 From $646
A Quick Look at Today's Ratings for Elevance Health(ELV.US), With a Forecast Between $530 to $643
On Jul 18, major Wall Street analysts update their ratings for $Elevance Health(ELV.US)$, with price targets ranging from $530 to $643.Morgan Stanley analyst Erin Wright maintains with a buy rating,
Elevance Health Cut to Neutral From Buy by B of A Securities
Elevance Health Cut to Neutral From Buy by B of A
Elevance Health (ELV) Receives a Buy From Truist Financial
Express News | Elevance Health : Deutsche Bank Raises Target Price to $565 From $558
Express News | B of A Securities Downgrades Elevance Health to Neutral, Lowers Price Target to $530
Elevance Health Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 07/18/2024 2.91% B of A Securities $646 → $530 Downgrades Buy → Neutral 07/15/2024 20.38% Truist